Zura Bio
(NASDAQ) ZURA
Zura Bio Financials at a Glance
Market Cap
$538.92M
Revenue (TTM)
$0.00
Net Income (TTM)
$99.35M
EPS (TTM)
$-1.19
P/E Ratio
-4.77
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Price
$5.75
Volume
10,844
Open
$5.79
Price
$5.75
Volume
10,844
Open
$5.79
Previous Close
$5.68
Daily Range
$5.70 - $5.85
52-Week Range
$0.98 - $7.44
Dividend
$0.00
Beta (Volatility)
0.61 (Low)
Price
$5.75
Volume
10,844
Open
$5.79
Previous Close
$5.68
Daily Range
$5.70 - $5.85
52-Week Range
$0.98 - $7.44
ZURA News
ZURA: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Zura Bio
Industry
Biotechnology
Sector
Health CareEmployees
40
CEO
Kimberly Ann Davis
Website
zurabio.comHeadquarters
San Diego, CA 92037, US
ZURA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-80%
Return on Capital
-74%
Return on Assets
-87%
Earnings Yield
-20.96%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$538.92M
Shares Outstanding
94.88M
Volume
10.84K
Short Interest
0.00%
Avg. Volume
663.54K
Financials (TTM)
Gross Profit
$49.00K
Operating Income
$75.25M
EBITDA
$75.25M
Operating Cash Flow
$64.81M
Capital Expenditure
$113.00K
Free Cash Flow
$64.93M
Cash & ST Invst.
$109.41M
Total Debt
$0.00
Zura Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$15.00K
-200.0%
Gross Margin
0.00%
N/A
Market Cap
$538.92M
N/A
Market Cap/Employee
$17.96M
N/A
Employees
30
N/A
Net Income
$45.88M
-407.1%
EBITDA
$18.41M
-35.2%
Quarterly Fundamentals
Net Cash
$109.41M
-38.0%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-87.19%
N/A
Return on Invested Capital
-74.11%
N/A
Free Cash Flow
$22.30M
-105.1%
Operating Cash Flow
$22.28M
-105.8%